Emergent Biosolutions EBS Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's change in accrued liabilities?
- Emergent Biosolutions (EBS) reported change in accrued liabilities of -$1.8M in Q1 2026.
- How has Emergent Biosolutions's change in accrued liabilities changed year-over-year?
- Emergent Biosolutions's change in accrued liabilities increased by 75.0% year-over-year, from -$7.2M to -$1.8M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.